MEBENDAZOLE TABLETS
Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Ürün özellikleri
(SPC)
13-05-2024
Bu ürün için bazı belgeler şu anda mevcut değil, müşteri hizmetlerimize bir istek gönderebilirsiniz ve bunları alır almaz size bildireceğiz.
İstek gönder.
İstek gönder.
Aktif bileşen:
MEBENDAZOLE
Mevcut itibaren:
Cupal Limited
Doz:
100 Milligram
Yetkilendirme tarihi:
2003-09-05
Ürün özellikleri
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Mebendazole Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Mebendazole 100 mg.
_For excipients, see 6.1._
3 PHARMACEUTICAL FORM
Chewable tablet
Mottled, pale orange, round tablets, shallow, concave with a breakline.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For the treatment of threadworm (enterobiasis) infestation.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults, the elderly and children over two years old:
One tablet to be chewed or swallowed whole. The efficacy in threadworm infestations is such that treatment failure
will be rare. However, the possibility of re-infection means that some patients may require a second tablet after two
weeks, if re-infected.
It is strongly recommended that all members of the family are treated at the same time.
Not recommended for children under two years of age.
4.3 CONTRAINDICATIONS
Pregnancy: Mebendazole has not been studied extensively in children under two years of age - for this reason it is not
currently recommended for children under two years of age.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
1.
Not to be taken during pregnancy, or whilst breast feeding.
2.
Not recommended for children under two years.
3.
Keep out of the reach and sight of children.
4.
If after two weeks you need to take a second tablet following which your symptoms persist, then consult your
doctor.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None stated.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 12/04/2010_
_CRN 2080858_
_page number: 1_
4.6 PREGNANCY AND LACTATION
Mebendazole has shown embryotoxic and teratogenic activity in rats at single oral doses. N
Belgenin tamamını okuyun
